| Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866) |
|---|
| 07/19/2011 | US7981620 Artificial antibody polypeptides |
| 07/19/2011 | US7981608 Device and method for high-throughput quantification of MRNA from whole blood |
| 07/19/2011 | US7981434 Surface exposed immunoglobulin D-binding protein from Moraxella catarrhalis |
| 07/19/2011 | US7981427 has a low level of homology to the enteric canine coronavirus, but which has a high level of homology to all bovine coronavirus strains (eg Quebec and LY138) and human coronavirus strain OC43 |
| 07/19/2011 | US7981413 Using cell surface adhesion proteins specific immunoglobulin to target therapeutics to tumorous; immunodiagnostics; immunotherapy |
| 07/19/2011 | US7981411 Use of live bacteria for growth promotion in animals |
| 07/19/2011 | CA2599914C Lectin isolated from bryopsis maxima that binds high-mannose-type sugar chains, used to purify chicken antibodies |
| 07/19/2011 | CA2479736C Metabolic engineering for improved xylose utilisation of saccharomyces cerevisiae |
| 07/19/2011 | CA2443208C Method for increasing productivity of secondary metabolite by conferring drug-resistant mutations |
| 07/19/2011 | CA2435606C Expression of recombinant proteinase k from tritirachium album in yeast |
| 07/19/2011 | CA2433501C Bhlh-pas proteins, genes thereof and utilization of the same |
| 07/19/2011 | CA2419254C Compositions and methods for detecting target microorganisms in a sample |
| 07/19/2011 | CA2410072C Polymerase cleavage agents and detection of rna |
| 07/19/2011 | CA2401906C Kcnb: a novel potassium channel protein |
| 07/19/2011 | CA2398155C Methods and compositions for linking binding domains in nucleic acid binding proteins |
| 07/19/2011 | CA2314663C A composition for providing long term stability to cells for diagnostic testing |
| 07/19/2011 | CA2291740C Use of recombinant human uteroglobin in treatment of inflammatory and fibrotic conditions |
| 07/19/2011 | CA2185656C Protein tyrosine kinase agonist antibodies |
| 07/19/2011 | CA1341618C Isolation cloning and expression of primate gm-csf |
| 07/14/2011 | WO2011085071A2 Attenuated francisella mutants and methods of use |
| 07/14/2011 | WO2011084414A1 Use of marine algae for producing hydrocarbons |
| 07/14/2011 | WO2011083354A1 Lactobacilli with anti-oxidant action |
| 07/14/2011 | WO2011083195A1 Thermophilic heterotrophic bacterial microorganism of the genus ureibacillus and use thereof for the production of sulphates |
| 07/14/2011 | WO2011083194A1 Thermophilic heterotrophic microorganism of the bacterial species brevibacillus thermoruber and use thereof for the production of sulphates |
| 07/14/2011 | WO2011083076A1 Improved recovery of nucleic acids from magnetic glass particles |
| 07/14/2011 | WO2011082455A1 Endophytes and related methods |
| 07/14/2011 | WO2011058446A3 Thebaine 6-o-demethylase and codeine o-demethylase from papaver somniferum |
| 07/14/2011 | WO2010151880A3 Increasing lifespan by modulating crtc expression or localization, and methods of screening for modulators of same |
| 07/14/2011 | WO2010070453A8 Meningococcal vaccines including hemoglobin receptor |
| 07/14/2011 | US20110173722 Novel insulin derivatives having an extremely delayed time-action profile |
| 07/14/2011 | US20110173716 EPSP synthase with high glyphosate resistance and its encoded sequence |
| 07/14/2011 | US20110173710 Chimeric meganuclease enzymes and uses thereof |
| 07/14/2011 | US20110172398 Bispecific binding molecules for anti-angiogenesis therapy |
| 07/14/2011 | US20110172295 METHODS AND COMPOSITIONS FOR THE REGULATION OF microRNA PROCESSING |
| 07/14/2011 | US20110172290 Isoforms of eIF-5A: Senescence-induced eIF5A; Wounding-induced elF-5A; Growth elF-5A; and DHS |
| 07/14/2011 | US20110172170 Interferon-like protein zcyto21 |
| 07/14/2011 | US20110172165 Modified linkers |
| 07/14/2011 | US20110172146 Growth hormone polypeptides and methods of making and using same |
| 07/14/2011 | US20110172114 Compositions and methods for the treatment of immune related diseases |
| 07/14/2011 | US20110171751 Recombinant polypeptides for diagnosing infection with trypanosoma cruzi |
| 07/14/2011 | US20110171722 Bacillus Licheniformis and Method for Detoxification of Zearalenone |
| 07/14/2011 | US20110171721 Targeted Gene Deletions for Polysaccharide Slime Formers |
| 07/14/2011 | US20110171718 Proteases With Modified Pre-Pro Regions |
| 07/14/2011 | US20110171711 Methods and Compositions for Production of Methane Gas |
| 07/14/2011 | US20110171705 Process for the production of alcohol |
| 07/14/2011 | US20110171704 Method for producing lactic acid from plant-derived raw material, and lactic-acid-producing bacterium |
| 07/14/2011 | US20110171703 Bacterium capable of producing lactic acid, and method for producing lactic acid |
| 07/14/2011 | US20110171702 Recombinant cell producing 2-hydroxyisobutyric acid |
| 07/14/2011 | US20110171699 Preparation of 6-aminocaproic acid from 5 -formyl valeri c acid |
| 07/14/2011 | US20110171698 C-22 hydroxylase |
| 07/14/2011 | US20110171693 Amylases, nucleic acids encoding them and methods for making and using them |
| 07/14/2011 | US20110171692 Process for amplifying dna in cells |
| 07/14/2011 | US20110171691 Genetically modified strains for biotransformations in anthracycline production |
| 07/14/2011 | US20110171678 Modified carbocyanine dyes and their conjugates |
| 07/14/2011 | US20110171674 Beta-Glucosidase Variants Having Improved Activity, and Uses Thereof |
| 07/14/2011 | US20110171669 Isolated luciferase gene of L. ITALICA |
| 07/14/2011 | US20110171667 Reaction medium for detecting and/or identifying bacteria of the legionella genus |
| 07/14/2011 | US20110171627 Zcytor19 heterodimeric cytokine receptor polynucleotides, polypeptides, antibodies and methods |
| 07/14/2011 | US20110171266 Malaria vaccine |
| 07/14/2011 | US20110171263 Compositions and methods of use of orf-1358 from beta-hemolytic streptococcal strains |
| 07/14/2011 | US20110171253 Novel astrovirus |
| 07/14/2011 | US20110171252 Streptococcus suis vaccines and diagnostic tests |
| 07/14/2011 | US20110171251 Piscirickettsia salmonis antigens and use thereof |
| 07/14/2011 | US20110171244 Recombinant protein carrying human papillomavirus epitopes inserted in an adenylate cyclase protein or fragment thereof therapeutic uses thereof |
| 07/14/2011 | US20110171238 Novel stra6 polypeptides |
| 07/14/2011 | US20110171237 Phep, an amino acid permease of staphylococcus aureus |
| 07/14/2011 | US20110171233 Antibodies Against Human Cytomegalovirus (HCMV) |
| 07/14/2011 | US20110171225 Novel Plasmodium Falciparum Gene Encoding Signal Peptide Peptidase and Method of Using Inhibitors Thereof for Inhibiting Malarial Infection |
| 07/14/2011 | US20110171222 Anti-her3 antibodies and uses thereof |
| 07/14/2011 | US20110171218 Compositions and methods for increasing serum half-life |
| 07/14/2011 | US20110171205 Novel 15571, 2465, 14266, 2882, 52871, 8203 and 16852 molecules and uses therefor |
| 07/14/2011 | US20110171173 Ifn-alpha/beta-independent mechanism of antiviral protection through a novel ligand-receptor pair: ifn- ligands engage a novel receptor ifn-rn (crf2-12) and il-10r2 (crf2-4) for signaling andinduction of biological activities |
| 07/14/2011 | US20110171170 Cytotoxic t cell defined egfr peptide and an optimized derivative peptide |
| 07/14/2011 | CA2786644A1 Improved recovery of nucleic acids from magnetic glass particles |
| 07/14/2011 | CA2785226A1 Photo-inactivated viruses and systems and methods of using the same |
| 07/13/2011 | EP2343367A1 Mutated Abl kinase domains |
| 07/13/2011 | EP2343366A1 Mutated Abl kinase domains |
| 07/13/2011 | EP2343365A1 Mutated Abl kinase domains |
| 07/13/2011 | EP2343363A1 Methods of isolating cells and generating monoclonal antibodies involving single epitope multiple staining |
| 07/13/2011 | EP2343317A1 Apolipoprotein analogues |
| 07/13/2011 | EP2343308A2 Novel immunogenic compositions for the prevention and treatment of meningococcal disease |
| 07/13/2011 | EP2343086A2 Antibodies to CD40 |
| 07/13/2011 | EP2343085A2 Antibody against prostate stem cell antigen (PSCA) |
| 07/13/2011 | EP2342346A2 Energy production with hyperthermophilic organisms |
| 07/13/2011 | EP2342336A2 Continuous directed evolution of proteins and nucleic acids |
| 07/13/2011 | EP1647593B1 Method for producing l-histidine using bacteria of the enterobacteriaceae family |
| 07/13/2011 | EP1465990B1 Truncated lysostaphin molecule with enhanced staphylolytic activity |
| 07/13/2011 | EP1305430B1 Mutant trichoderma reesei egiii cellulases, dna encoding such egiii compositions and methods for obtaining same |
| 07/13/2011 | EP1289553B1 Nrg-2 nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods |
| 07/13/2011 | EP1223814B1 Method for the preparation of attenuated starter cultures |
| 07/13/2011 | EP0897428B2 Test media and quantitative method for identification and differentiation of biological materials in a test sample |
| 07/13/2011 | CN102124598A Fuel cell, process for manufacture of fuel cell, electronic device, enzyme-immobilized electrode, biosensor, energy conversion element, cell, cell organelle, and bacterium |
| 07/13/2011 | CN102124117A Ethanol production using xylitol synthesis mutant of xylose-utilizing zymomonas |
| 07/13/2011 | CN102124116A Method for extracting phosphorous from solids using active leaching and phosphate-accumulating microorganisms |
| 07/13/2011 | CN102124113A Plant promoters of the XVSAP1 gene |
| 07/13/2011 | CN102124112A Homologous recombination-based DNA cloning methods and compositions |
| 07/13/2011 | CN102124097A Bacterial composition |
| 07/13/2011 | CN102123955A Processing of water using microorganisms |
| 07/13/2011 | CN102123615A Temperature-induced delivery of nutrients by micro-organisms in the gastrointestinal tract |
| 07/13/2011 | CN102121025A Multi-copy integrated expression vector and preparation method and application thereof in expression of bovine lactoferrin |